| Q41191006 | A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells |
| Q61806047 | Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype |
| Q64120898 | Effects of SIRT1 silencing on viability, invasion and metastasis of human glioma cell lines |
| Q90708150 | Expression and function of FRA1 protein in tumors |
| Q64077951 | Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner |
| Q37745174 | Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway |
| Q41072269 | MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells |
| Q91656884 | Metabolic Plasticity and Epithelial-Mesenchymal Transition |
| Q64991694 | MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133+ hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway. |
| Q98945434 | MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway |
| Q47098435 | MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway |
| Q53701150 | MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1. |
| Q48197662 | Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. |
| Q64944856 | Prognostic significance of lymphovascular invasion in colorectal cancer and its association with genomic alterations. |
| Q58726244 | Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells |
| Q88091799 | Reply to 'Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'' |
| Q64279864 | Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer |
| Q49646710 | SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells |
| Q51734190 | SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling. |
| Q50149096 | Sirtuin 7 promotes colorectal carcinoma proliferation and invasion through the inhibition of E-cadherin |
| Q64097816 | Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis |
| Q89464800 | The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors |
| Q94570239 | The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door |
| Q42371635 | The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis |
| Q94496782 | Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis |
| Q33873143 | β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells |